Evaluation of Gadopiclenol and P846, 2 High-Relaxivity Macrocyclic Magnetic Resonance Contrast Agents Without Protein Binding, in a Rodent Model of Hepatic Metastases: Potential Solutions for Improved Enhancement at Ultrahigh Field StrengthPurpose The aim of this study was to evaluate in vitro and in vivo the enhancement properties of experimental gadolinium (Gd)-based contrast agents (GBCAs) with different molecular weights and hydration numbers (P846 and gadopiclenol) compared with clinically approved low-molecular, extracellular agents (gadopentetate and gadoterate) at 9.4 T and to discuss influencing factors on r1 relaxivities. Methods and Materials All experiments were performed with a 9.4 T animal scanner (Bruker, Germany). We performed relaxometry measurements for all contrast agents in human plasma at 37°C using an IR-RARE sequence. In addition, we compared P846 with gadopentetate and gadopiclenol with gadoterate intraindividually in rats with hepatic colorectal cancer metastases (n = 10 each) acquiring T1-weighted FLASH sequences before and at 10 consecutive time points during 20 minutes. After intravenous contrast agent application, signal-to-noise ratios (SNRs), contrast-to-noise ratios (CNRs), and lesion enhancement (LE) for liver parenchyma and tumors were calculated based on region of interest measurements. Results Longitudinal relaxivities (r1) of the low-molecular agents were lower as compared with the experimental compounds. However, r1 of gadopentetate and gadoterate demonstrated only a moderate decrease of r1 at 9.4 T as compared with known data at lower field strengths (gadopentetate: r1 [at 9.4 T], 3.4 mM−1 s−1/r1 [at 1.5 T], 4.1 mM−1 s−1/gadoterate: r1 [at 9.4 T], 3.1 mM−1 s−1/r1 [at 1.5 T], 3.6 mM−1 s−1). In contrast, r1 of P846 showed a marked reduction at 9.4 T compared with 1.5 T (P846: r1 [at 9.4 T], 6.4 mM−1 s−1/r1 [at 1.5 T], 32 mM−1 s−1). Gadopiclenol provided the highest r1 in this study at 9.4 T and the drop of r1 as compared with lower field strength is less apparent (gadopiclenol: r1 [at 9.4 T], 8.7 mM−1 s−1/r1 [at 1.5 T], 12.7 mM−1 s−1). In vivo, P846 and gadopiclenol showed significantly higher SNR, CNR, and LE as compared with the low-molecular control agents (mean ± SD; SNRliver [gadopentetate, 18.1 ± 1.2; P846, 27.2 ± 1.5; P < 0.001]; SNRtumor [gadopentetate, 22.6 ± 1.9; P846, 40.1 ± 1.9; P < 0.001]; CNR [gadopentetate, 4.6 ± 1.0; P846, 12.9 ± 0.9; P < 0.001]; LE [gadopentetate, 7.2 ± 1.9; P846, 14.9 ± 1.9; P < 0.001]/SNRliver [gadoterate, 8.8 ± 0.5; gadopiclenol, 12.6 ± 1.3; P < 0.001]; SNRtumor [gadoterate, 11.3 ± 1.2; gadopiclenol, 20.9 ± 2.9; P < 0.001]; CNR [gadoterate, 2.5 ± 0.7; gadopiclenol, 8.3 ± 1.7; P < 0.001]; LE [gadoterate, 4.4 ± 1.2; gadopiclenol, 13.0 ± 2.9; P < 0.001]). Thus, for equal Gd doses, gadopiclenol and P846 increase the CNR of liver metastases by a factor of 2.5 to 3 at 9.4 T compared with gadoterate and gadopentetate. Conclusions P846 and gadopiclenol provide superior enhancement at 9.4 T as compared with gadopentetate and gadoterate. However, the macromolecular agent P846 shows a marked decrease of r1 from 1.5 T to 9.4 T. This effect is less apparent for the low-molecular agents gadopiclenol, gadopentetate, and gadoterate. Yet, based on the higher hydration number, r1 of P846 and gadopiclenol are markedly higher as compared with the reference contrast agents. Thus, building compounds with moderately increased molecular size and hydration number, as implemented in gadopiclenol, seems to be a promising way to develop highly effective GBCAs. Advantages for gadopiclenol include a strong enhancement regardless of the external magnetic field strength, pharmacokinetics comparable to those of clinically approved extracellular GBCAs, and the potential to either improve sensitivity in diagnostic magnetic resonance imaging by improving lesion conspicuity or to perform studies with significantly reduced Gd-dose while at the same time providing comparable diagnostic accuracy. However, all this needs to be proven in clinical studies. Received for publication February 17, 2019; and accepted for publication, after revision, March 19, 2019. Conflicts of interest and sources of funding: This project was in part supported by research grant no. 0314101 from the BMBF (German Ministry of Education and Research). The authors report no conflicts of interest. Correspondence to: Peter Fries, MD, Clinic for Diagnosis and Interventional Radiology, Saarland University Medical Center, Bldg 50.1, Kirrberger Strasse 66421 Homburg, Germany. E-mail: drpeterfries@googlemail.com. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
Αρχειοθήκη ιστολογίου
-
▼
2019
(11718)
-
▼
Μαΐου
(1970)
- Medicine by Alexandros G. Sfakianakis,Anapafseos 5...
-
Pulmonary pleomorphic carcinoma harboring epide...
-
Cervical cancer with breast metastasisChing-Tin...
-
Inflammatory Pseudotumor of the LiverTsen-Long ...
-
Pembrolizumab-induced uveitis in a patient with...
-
Detection of anaplastic lymphoma kinase gene re...
-
A Patient with refractory metastatic germ cell ...
-
Modulation of oxidative stress by doxorubicin l...
-
Antiproliferative effect of oxidative stress in...
-
High-intensity focused ultrasound for localized...
-
Prevention and management catheter-associated uri...
-
people suffering from special phobiasAlireza Sang...
-
singing on the happiness of older peopleMaryam En...
-
Modeling of cardiac function of patients with a...
-
patients with spinal muscular atrophy
,Ali-Asghar...
-
Effect of cognitive behavior therapy integrated w...
-
Warning System Designed to Predict Severe Sepsis ...
-
Neurologic Complications of Infective Endocardi...
-
Myeloid-Derived Suppressor Cells Mediate Immunosu...
-
Tumour Spheroids-on-a-Chip
,M Ibrahim Khot, Mark ...
- Cancer Research and Practice
- Nursing and Midwifery Sciences
- Critical Care Medicine
- Podcast: Being a Professional Musician with Bipola...
- Medicine by Alexandros G. Sfakianakis,Anapafseos 5...
-
Adjuvant therapies in venous leg ulcer management...
-
Pressure Ulcer Summit 2018: An Interdisciplinary ...
-
Leukemia inhibitory factor promotes the regenerat...
-
Toll like receptors (TLRs) in response to human...
-
Evaluation of hypercalciuria in patients receiv...
-
Cytochemical tests to investigate sperm DNA dam...
- Family Medicine and Primary Care
-
IL‐17A is not a treatment target in progressiv...
-
The next‐generation BET inhibitor, PLX51107, d...
- Otolaryngology & Head and Neck Surgery
- Tropical Medicine
-
Treating the primary in metastatic prostate cance...
-
Cytoreductive nephrectomy in metastatic kidney ...
-
Treating advanced penile cancer: where do we st...
-
Supplemental oxygen for the management of dyspn...
-
Multidimensional measurement of breathlessness:...
-
Interdisciplinary management of chronic breath...
- Supportive and Palliative Care
- Organ Transplantation
-
Serum carcinoembryonic antigen to predict recurre...
-
Precision medicine in the ageing world: The role ...
-
Prognostic roles of microRNA 143 and microRNA 145...
-
Elevated neutrophil to lymphocyte and platelet to...
-
Associated measurement of fucosylated levels of A...
-
Clinicopathological and prognostic significance o...
-
β-Arrestin-1 expression and epithelial-to-mesench...
-
Prognostic nomogram for patients with non-metasta...
-
Clinicopathological and molecular differences in ...
-
Performance of a MethyLight assay for methylated ...
-
Cell-free microRNAs as non-invasive biomarkers in...
-
Urinary markers in treatment monitoring of lung c...
-
Circular RNA ABCB10 promotes tumor progression an...
-
Predictive significance of CYFRA21-1, squamous ce...
-
Clinical significance of tumor miR-21, miR-221, m...
-
The serum level of CC chemokine ligand 18 correla...
-
iTRAQ-based proteomics reveals SOD2 as a potentia...
-
New and old biomarkers in the differential diagno...
-
Prognostic markers affecting the early recurrence...
-
Cancer registries - guardians of breast cancer bi...
-
Automated Pupillometry Devices in Critically Il...
-
Language Monitoring in Brain Surgery Under Gene...
-
Subanesthetic Dose of Ketamine Improved CFA-ind...
-
Defining a Taxonomy of Intracranial Hypertensio...
-
Pain Anxiety as a Mechanism Linking Pain Severi...
-
The Association Between Antenatal Maternal Self...
-
Prenatal Practice Staff Perceptions of Three Su...
-
Exploring the Effects of Vitamin D Supplementat...
-
How Might Maternal Poverty Impact the Course of...
-
Poverty and Excess Length of Hospital Stay in Neo...
-
The Effect of Depth of Anesthesia on Hemodynam...
- Neurosurgical Anesthesiology
- Addiction Medicine
- Vehicle Collision : Blunt rupture of the myocardiu...
-
Variability in international normalized ratio a...
-
Promotility Agents For The Treatment Of Ileus I...
-
Ketamine Infusion for Pain Control in Adult Pat...
-
Resuscitative Endovascular Balloon Occlusion of...
- Trauma and Acute Care Surgery
-
Unfractionated heparin attenuates histone-mediat...
-
Wall Contrast Enhancement of Thrombosed Intracran...
-
Assessment of Explicitly Stated Interval Change o...
-
Deep Learning–Based Automatic Segmentation of Lum...
- Hazardous Materials
- Sugar Alternatives : Molasses,Raw Honey,Stevia,Xyl...
- The Hearing Journal
- Molecular markers used to guide treatment, assess ...
- Programmed death-ligand 1 (PD-L1) also known as cl...
- Anaplastic lymphoma kinase (ALK) also known as ALK...
- Proto-oncogene tyrosine-protein kinase ROS is an e...
- The KRAS gene provides instructions for making a p...
- Amplification, also known as the over-expression o...
- Mutations that lead to EGFR overexpression (known ...
- A BRCA mutation is a mutation in either of the BRC...
- BRAF is a human gene that encodes a protein called...
-
Differences in the Intended Meaning of Congest...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου